AP2016009008A0 - Polymorph of syk inhibitors - Google Patents

Polymorph of syk inhibitors

Info

Publication number: AP2016009008A0
Authority: AP; ARIPO
Prior art keywords: polymorph; syk inhibitors; syk; inhibitors
Prior art date: 2013-07-30

Application number

AP2016009008A

Other languages

English (en)

Inventor

Peter Chee-Chu Fung

Dimitrios Stefanidis

Dragos Vizitiu

Tim G Elford

Michael Laird Hurrey

Original Assignee

Gilead Connecticut Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-07-30

Filing date

2014-07-29

Publication date

2016-01-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51301367&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2016009008(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-07-29 Application filed by Gilead Connecticut Inc filed Critical Gilead Connecticut Inc

2016-01-31 Publication of AP2016009008A0 publication Critical patent/AP2016009008A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Orthopedic Medicine & Surgery (AREA)
Transplantation (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Steroid Compounds (AREA)

AP2016009008A 2013-07-30 2014-07-29 Polymorph of syk inhibitors AP2016009008A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201361860197P	2013-07-30	2013-07-30
PCT/US2014/048733 WO2015017460A1 (en)	2013-07-30	2014-07-29	Polymorph of syk inhibitors

Publications (1)

Publication Number	Publication Date
AP2016009008A0 true AP2016009008A0 (en)	2016-01-31

Family

ID=51301367

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2016009008A AP2016009008A0 (en)	2013-07-30	2014-07-29	Polymorph of syk inhibitors

Country Status (32)

Country	Link
US (4)	US20160168155A1 (es)
EP (1)	EP3027618B1 (es)
JP (1)	JP6230709B2 (es)
KR (1)	KR101810798B1 (es)
CN (1)	CN105452252A (es)
AP (1)	AP2016009008A0 (es)
AR (1)	AR097158A1 (es)
AU (2)	AU2014296308C1 (es)
CA (1)	CA2919661C (es)
CL (1)	CL2016000238A1 (es)
CR (1)	CR20160098A (es)
DK (1)	DK3027618T3 (es)
EA (2)	EA029281B1 (es)
ES (1)	ES2822285T3 (es)
HK (1)	HK1222390A1 (es)
HR (1)	HRP20201582T1 (es)
HU (1)	HUE052090T2 (es)
IL (1)	IL243579A0 (es)
MD (1)	MD4659B1 (es)
MX (1)	MX2016001304A (es)
MY (1)	MY176803A (es)
NZ (1)	NZ715776A (es)
PE (1)	PE20160862A1 (es)
PH (1)	PH12016500169A1 (es)
PL (1)	PL3027618T3 (es)
PT (1)	PT3027618T (es)
SG (1)	SG11201600385TA (es)
SI (1)	SI3027618T1 (es)
SV (1)	SV2016005149A (es)
TW (1)	TW201602108A (es)
UY (1)	UY35683A (es)
WO (1)	WO2015017460A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2011006094A (es)	2008-12-08	2011-11-29	Gilead Connecticut Inc	Inhibidores de imidazopirazina syk.
BR112012022943A2 (pt)	2010-03-11	2018-06-05	Gilead Connecticut Inc	inibidores de syk de imidazopiridnas
PT3027171T (pt) *	2013-07-30	2020-06-18	Gilead Connecticut Inc	Formulação de inibidores da syk
MX2016001304A (es) *	2013-07-30	2016-04-07	Gilead Connecticut Inc	Polimorfo de inhibidores de syk.
SG11201603050TA (en)	2013-12-04	2016-05-30	Gilead Sciences Inc	Methods for treating cancers
US9290505B2 (en)	2013-12-23	2016-03-22	Gilead Sciences, Inc.	Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
TWI735853B (zh)	2013-12-23	2021-08-11	美商克洛諾斯生技有限公司	脾酪胺酸激酶抑制劑
MX2017000610A (es)	2014-07-14	2017-04-27	Gilead Sciences Inc	Metodos combinados para tratar canceres.
TW201639573A (zh)	2015-02-03	2016-11-16	吉李德科學股份有限公司	有關治療癌症之合併治療
CA2983611A1 (en)	2015-04-21	2016-10-27	Gilead Sciences, Inc.	Treatment of chronic graft versus host disease with syk inhibitors
US20170173034A1 (en)	2015-12-17	2017-06-22	Gilead Sciences, Inc.	Combination of a jak inhibitor and a syk inhibitor for treating cancers and inflammatory disorders
WO2017144010A1 (zh) *	2016-02-26	2017-08-31	苏州晶云药物科技有限公司	(6-(1H-吲唑-6-基)-N-[4-(4-吗啉基)苯基]咪唑并[1，2-a]吡嗪-8-胺)甲磺酸盐的新晶型
TW201822764A (zh)	2016-09-14	2018-07-01	美商基利科學股份有限公司	Syk抑制劑
US10111882B2 (en)	2016-09-14	2018-10-30	Gilead Sciences, Inc.	SYK inhibitors
JOP20180040A1 (ar)	2017-04-20	2019-01-30	Gilead Sciences Inc	مثبطات pd-1/pd-l1
WO2018195471A1 (en)	2017-04-21	2018-10-25	Gilead Sciences, Inc.	Syk inhibitors in combination with hypomethylating agents
CN115028640A (zh) *	2017-08-25	2022-09-09	吉利德科学公司	Syk抑制剂的多晶型物
JP7062792B2 (ja)	2018-02-13	2022-05-06	ギリアードサイエンシーズ，インコーポレイテッド	Ｐｄ－１／ｐｄ－ｌ１阻害剤
EP3781556B1 (en)	2018-04-19	2025-06-18	Gilead Sciences, Inc.	Pd-1/pd-l1 inhibitors
KR102732008B1 (ko)	2018-05-14	2024-11-20	길리애드 사이언시즈, 인코포레이티드	Mcl-1 억제제
MX2020012259A (es)	2018-05-18	2021-01-29	Novartis Ag	Formas cristalinas de un inhibidor de tlr7/tlr8.
CN118221646A (zh)	2018-07-13	2024-06-21	吉利德科学公司	Pd-1/pd-l1抑制剂
KR102635333B1 (ko)	2018-10-24	2024-02-15	길리애드 사이언시즈, 인코포레이티드	Pd-1/pd-l1 억제제
KR20210131372A (ko)	2019-02-22	2021-11-02	크로노스 바이오, 인코포레이티드	Syk 억제제로서의 축합된 피라진의 고체 형태
CN113402506B (zh) *	2021-06-17	2023-06-16	四川大学	中间体和制备方法及其在合成长春布宁上的应用

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2607813B1 (fr)	1986-12-05	1989-03-31	Montpellier I Universite	Alkylamino-8 imidazo (1,2-a) pyrazines et derives, leur preparation et leur application en therapeutique
US5137876A (en)	1990-10-12	1992-08-11	Merck & Co., Inc.	Nucleoside antiviral and anti-inflammatory compounds and compositions and methods for using same
DE4327027A1 (de)	1993-02-15	1994-08-18	Bayer Ag	Imidazoazine
DE4337611A1 (de)	1993-11-04	1995-05-11	Boehringer Ingelheim Kg	Neue Benzoylguanidine, ihre Herstellung und ihre Verwendung in Arzneimitteln
DE4337609A1 (de)	1993-11-04	1995-05-11	Boehringer Ingelheim Kg	Neue Pyrazincarboxamidderivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
FR2711993B1 (fr)	1993-11-05	1995-12-01	Rhone Poulenc Rorer Sa	Médicaments contenant des dérivés de 7H-imidazol[1,2-a]pyrazine-8-one, les nouveaux composés et leur préparation.
US6334997B1 (en)	1994-03-25	2002-01-01	Isotechnika, Inc.	Method of using deuterated calcium channel blockers
JP3696884B2 (ja)	1994-03-25	2005-09-21	アイソテクニカ、インコーポレーテッド	ジュウテリウム化による薬物の効能の増強
FR2723373B1 (fr)	1994-08-02	1996-09-13	Rhone Poulenc Rorer Sa	Forme purifiee de streptogramines, sa preparation et les compositions pharmaceutiques qui la contiennent
WO1996034866A1 (en)	1995-05-01	1996-11-07	Fujisawa Pharmaceutical Co., Ltd.	Imidazo 1,2-a pyridine and imidazo 1,2-a pyridezine derivatives and their use as bone resorption inhibitors
US5593997A (en)	1995-05-23	1997-01-14	Pfizer Inc.	4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors
SE9704404D0 (sv)	1997-11-28	1997-11-28	Astra Ab	New compounds
DE19948434A1 (de)	1999-10-08	2001-06-07	Gruenenthal Gmbh	Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine
JP2001302667A (ja)	2000-04-28	2001-10-31	Bayer Ag	イミダゾピリミジン誘導体およびトリアゾロピリミジン誘導体
GB0018473D0 (en)	2000-07-27	2000-09-13	Merck Sharp & Dohme	Therapeutic agents
DE10050663A1 (de)	2000-10-13	2002-04-18	Gruenenthal Gmbh	Verwendung von substituierten Imidazo[1,2-a]pyridin-, -pyrimidin- und pyrazin-3-yl-amin-Derivaten zur Herstellung von Medikamenten zur NOS-Inhibierung
WO2002060492A1 (en)	2001-01-30	2002-08-08	Cytopia Pty Ltd	Methods of inhibiting kinases
GB0103926D0 (en)	2001-02-17	2001-04-04	Astrazeneca Ab	Chemical compounds
WO2002076985A1 (en)	2001-03-23	2002-10-03	Smithkline Beecham Corporation	Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
JP2005523288A (ja)	2002-02-19	2005-08-04	ファルマシア・アンド・アップジョン・カンパニー・エルエルシー	疾病治療用の縮合した二環式−ｎ−架橋−複素環式芳香族カルボキサミド
IL164703A0 (en)	2002-04-19	2005-12-18	Cellular Genomics Inc	ImidazoÄ1,2-AÜpyrazin-8-ylamines method of making and method of use thereof
KR101060971B1 (ko)	2002-05-14	2011-09-01	제노바 리미티드	안트라닐산 유도체 수화물의 제조 방법
AU2003270489A1 (en)	2002-09-09	2004-03-29	Cellular Genomics, Inc.	6-ARYL-IMIDAZO(1,2-a)PYRAZIN-8-YLAMINES, METHOD OF MAKING, AND METHOD OF USE THEREOF
CA2499639C (en)	2002-09-19	2011-11-08	Schering Corporation	Imidazopyridines as cyclin dependent kinase inhibitors
JP2006503838A (ja)	2002-09-23	2006-02-02	シェーリング　コーポレイション	サイクリン依存性キナーゼインヒビターとしての新規イミダゾピラジン
ATE377600T1 (de)	2002-09-23	2007-11-15	Schering Corp	Imidazopyrazine als cdk-inhibitoren
US7160885B2 (en)	2003-02-10	2007-01-09	Cgi Pharmaceuticals, Inc.	Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activity
US7157460B2 (en)	2003-02-20	2007-01-02	Sugen Inc.	Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
US7186832B2 (en)	2003-02-20	2007-03-06	Sugen Inc.	Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
US20060183746A1 (en)	2003-06-04	2006-08-17	Currie Kevin S	Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
WO2005014599A1 (en)	2003-06-04	2005-02-17	Cellular Genomics, Inc.	Imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of bruton’s tyrosine kinase by such compounds
US7393848B2 (en)	2003-06-30	2008-07-01	Cgi Pharmaceuticals, Inc.	Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds
US7259164B2 (en)	2003-08-11	2007-08-21	Cgi Pharmaceuticals, Inc.	Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity
US20050288295A1 (en)	2003-11-11	2005-12-29	Currie Kevin S	Certain imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
US7973161B2 (en)	2003-11-13	2011-07-05	Abbott Laboratories	Apoptosis promoters
WO2005085252A1 (en)	2004-03-04	2005-09-15	Biofocus Discovery Limited	Imidazo ‘1,2-a’ pyrazine compounds which interact with protein kinases
EP1812439B2 (en)	2004-10-15	2017-12-06	Takeda Pharmaceutical Company Limited	Kinase inhibitors
WO2006053121A2 (en)	2004-11-10	2006-05-18	Cgi Pharmaceuticals, Inc.	Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity
DK1888550T3 (da)	2005-05-12	2014-09-29	Abbvie Bahamas Ltd	Apoptosepromotorer
AR056785A1 (es)	2005-11-10	2007-10-24	Schering Corp	COMPUESTOS DE IMIDAZO[1,2-A]PIRAZINAS, uTILES COMO INHIBIDORES, REGULADORES O MODULADORES DE PROTEINQUINASAS
CA2662074A1 (en)	2006-08-30	2008-03-06	Cellzome Limited	Triazole derivatives as kinase inhibitors
AR063706A1 (es)	2006-09-11	2009-02-11	Cgi Pharmaceuticals Inc	Determinadas amidas sustituidas, el uso de las mismas para el tratamiento de enfermedades mediadas por la inhibicion de la actividad de btk y composiciones farmaceuticas que las comprenden.
CL2008002793A1 (es)	2007-09-20	2009-09-04	Cgi Pharmaceuticals Inc	Compuestos derivados de amidas sustituidas, inhibidores de la actividad de btk; composicion farmaceutica que los comprende; utiles en el tratamiento del cancer, trastornos oseos, enfermedades autoinmunes, entre otras
AU2008329741B2 (en)	2007-11-28	2013-09-12	Irx Therapeutics, Inc.	Method of increasing immunological effect
CN101952283B (zh)	2007-12-14	2013-04-17	霍夫曼-拉罗奇有限公司	咪唑并[1，2-a]吡啶和咪唑并[1，2-b]哒嗪衍生物
US20090221612A1 (en)	2008-02-13	2009-09-03	Mitchell Scott A	Certain substituted amides, method of making, and method of use thereof
US20110002989A1 (en)	2008-03-07	2011-01-06	Pfizer Inc.	Methods, dosage forms and kits for administering ziprasidone without food
NZ601700A (en)	2008-06-24	2013-02-22	Hoffmann La Roche	5-phenyl-1H-pyridin-2-one and 6-phenyl-2H-pyridazin-3-one derivatives as inhibitors of Bruton's Tyrosine Kinase (Btk)
PL2300459T3 (pl)	2008-07-02	2013-10-31	Hoffmann La Roche	Nowe fenylopirazynony jako inhibitory kinazy
EP2307413B1 (en)	2008-07-15	2015-09-09	F. Hoffmann-La Roche AG	Novel phenyl-imidazopyridines and pyridazines
TWI453207B (zh)	2008-09-08	2014-09-21	Signal Pharm Llc	胺基三唑并吡啶，其組合物及使用其之治療方法
KR101745732B1 (ko)	2008-12-08	2017-06-12	질레드 코네티컷 인코포레이티드	이미다조피라진 ｓｙｋ 억제제
US8450321B2 (en) *	2008-12-08	2013-05-28	Gilead Connecticut, Inc.	6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
MX2011006094A (es)	2008-12-08	2011-11-29	Gilead Connecticut Inc	Inhibidores de imidazopirazina syk.
US8362013B2 (en)	2009-04-30	2013-01-29	Abbvie Inc.	Salt of ABT-263 and solid-state forms thereof
US8546399B2 (en)	2009-05-26	2013-10-01	Abbvie Inc.	Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
US10071059B2 (en)	2009-12-18	2018-09-11	Frieslandcampina Nederland Holding B.V.	Co-processed tablet excipient composition its preparation and use
BR112012022943A2 (pt)	2010-03-11	2018-06-05	Gilead Connecticut Inc	inibidores de syk de imidazopiridnas
JP6141188B2 (ja)	2010-11-23	2017-06-07	アッヴィ・インコーポレイテッド	アポトーシス誘導剤の塩および結晶の形態
JPWO2012147832A1 (ja) *	2011-04-27	2014-07-28	第一三共株式会社	フェニルピロール誘導体の結晶
US20130338142A1 (en)	2012-06-14	2013-12-19	Gilead Connecticut, Inc.	Imidazopyrazine syk inhibitors
CA2882134A1 (en)	2012-08-14	2014-02-20	Gilead Calistoga Llc	Combination therapies for treating cancer
US20140148430A1 (en)	2012-11-26	2014-05-29	Gilead Connecticut, Inc.	Imidazopyridines syk inhibitors
MX2016001304A (es)	2013-07-30	2016-04-07	Gilead Connecticut Inc	Polimorfo de inhibidores de syk.
PT3027171T (pt) *	2013-07-30	2020-06-18	Gilead Connecticut Inc	Formulação de inibidores da syk
SG11201600373YA (en)	2013-07-31	2016-02-26	Gilead Sciences Inc	Syk inhibitors
SG11201603050TA (en) *	2013-12-04	2016-05-30	Gilead Sciences Inc	Methods for treating cancers
TWI735853B (zh)	2013-12-23	2021-08-11	美商克洛諾斯生技有限公司	脾酪胺酸激酶抑制劑
US9290505B2 (en)	2013-12-23	2016-03-22	Gilead Sciences, Inc.	Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
AU2014370125B2 (en)	2013-12-23	2017-11-16	Gilead Sciences, Inc.	Synthesis of a macrocyclic HCV NS3 inhibiting tripeptide
MX2017000610A (es)	2014-07-14	2017-04-27	Gilead Sciences Inc	Metodos combinados para tratar canceres.
TW201617074A (zh)	2014-07-14	2016-05-16	吉李德科學股份有限公司	Ｓｙｋ（脾酪胺酸激酶）抑制劑
TW201639573A (zh)	2015-02-03	2016-11-16	吉李德科學股份有限公司	有關治療癌症之合併治療
CA2983611A1 (en)	2015-04-21	2016-10-27	Gilead Sciences, Inc.	Treatment of chronic graft versus host disease with syk inhibitors

2014
- 2014-07-29 MX MX2016001304A patent/MX2016001304A/es unknown
- 2014-07-29 ES ES14750289T patent/ES2822285T3/es active Active
- 2014-07-29 WO PCT/US2014/048733 patent/WO2015017460A1/en not_active Ceased
- 2014-07-29 CA CA2919661A patent/CA2919661C/en active Active
- 2014-07-29 DK DK14750289.2T patent/DK3027618T3/da active
- 2014-07-29 MY MYPI2016700285A patent/MY176803A/en unknown
- 2014-07-29 US US14/907,767 patent/US20160168155A1/en not_active Abandoned
- 2014-07-29 EA EA201690172A patent/EA029281B1/ru active IP Right Revival
- 2014-07-29 SI SI201431675T patent/SI3027618T1/sl unknown
- 2014-07-29 TW TW103125870A patent/TW201602108A/zh unknown
- 2014-07-29 NZ NZ715776A patent/NZ715776A/en not_active IP Right Cessation
- 2014-07-29 SG SG11201600385TA patent/SG11201600385TA/en unknown
- 2014-07-29 HU HUE14750289A patent/HUE052090T2/hu unknown
- 2014-07-29 EP EP14750289.2A patent/EP3027618B1/en active Active
- 2014-07-29 PT PT147502892T patent/PT3027618T/pt unknown
- 2014-07-29 MD MD20160017A patent/MD4659B1/ro not_active IP Right Cessation
- 2014-07-29 HK HK16110532.6A patent/HK1222390A1/zh unknown
- 2014-07-29 US US14/446,011 patent/US9657023B2/en active Active
- 2014-07-29 AP AP2016009008A patent/AP2016009008A0/xx unknown
- 2014-07-29 JP JP2016531837A patent/JP6230709B2/ja active Active
- 2014-07-29 KR KR1020167005206A patent/KR101810798B1/ko not_active Expired - Fee Related
- 2014-07-29 HR HRP20201582TT patent/HRP20201582T1/hr unknown
- 2014-07-29 PL PL14750289T patent/PL3027618T3/pl unknown
- 2014-07-29 AU AU2014296308A patent/AU2014296308C1/en not_active Ceased
- 2014-07-29 CN CN201480043503.5A patent/CN105452252A/zh active Pending
- 2014-07-29 EA EA201791873A patent/EA201791873A1/ru unknown
- 2014-07-29 PE PE2016000197A patent/PE20160862A1/es unknown
- 2014-07-30 AR ARP140102857A patent/AR097158A1/es unknown
- 2014-07-30 UY UY35683A patent/UY35683A/es not_active Application Discontinuation
2016
- 2016-01-12 IL IL243579A patent/IL243579A0/en unknown
- 2016-01-25 PH PH12016500169A patent/PH12016500169A1/en unknown
- 2016-01-29 CL CL2016000238A patent/CL2016000238A1/es unknown
- 2016-01-29 SV SV2016005149A patent/SV2016005149A/es unknown
- 2016-02-29 CR CR20160098A patent/CR20160098A/es unknown
2017
- 2017-04-11 US US15/484,844 patent/US20170217967A1/en not_active Abandoned
- 2017-09-08 AU AU2017225136A patent/AU2017225136A1/en not_active Abandoned
- 2017-10-19 US US15/788,583 patent/US10266539B2/en active Active

Also Published As

Publication number	Publication date
PH12016500169A1 (en)	2016-04-25
US9657023B2 (en)	2017-05-23
JP2016527268A (ja)	2016-09-08
PT3027618T (pt)	2020-10-12
MD20160017A2 (ro)	2016-08-31
AU2014296308C1 (en)	2018-09-13
HRP20201582T1 (hr)	2021-02-19
CL2016000238A1 (es)	2016-07-22
NZ715776A (en)	2017-04-28
AR097158A1 (es)	2016-02-24
MX2016001304A (es)	2016-04-07
HUE052090T2 (hu)	2021-04-28
UY35683A (es)	2015-02-27
EA201791873A1 (ru)	2018-09-28
EA029281B1 (ru)	2018-03-30
MD4659B1 (ro)	2019-11-30
AU2017225136A1 (en)	2017-10-05
EP3027618B1 (en)	2020-07-08
EA201690172A1 (ru)	2016-07-29
WO2015017460A1 (en)	2015-02-05
CR20160098A (es)	2016-07-11
HK1222390A1 (zh)	2017-06-30
CA2919661A1 (en)	2015-02-05
AU2014296308A1 (en)	2016-02-04
ES2822285T3 (es)	2021-04-30
AU2014296308B2 (en)	2017-06-08
JP6230709B2 (ja)	2017-11-15
US20150038505A1 (en)	2015-02-05
PL3027618T3 (pl)	2021-04-19
US20180099971A1 (en)	2018-04-12
US20170217967A1 (en)	2017-08-03
EP3027618A1 (en)	2016-06-08
IL243579A0 (en)	2016-02-29
US20160168155A1 (en)	2016-06-16
SI3027618T1 (sl)	2021-01-29
KR101810798B1 (ko)	2017-12-19
SV2016005149A (es)	2017-04-03
CN105452252A (zh)	2016-03-30
SG11201600385TA (en)	2016-02-26
CA2919661C (en)	2020-08-18
MY176803A (en)	2020-08-21
PE20160862A1 (es)	2016-09-24
TW201602108A (zh)	2016-01-16
KR20160038007A (ko)	2016-04-06
DK3027618T3 (da)	2020-10-12
US10266539B2 (en)	2019-04-23

Publication	Publication Date	Title
IL243579A0 (en)	2016-02-29	A polymorph of syk inhibitors
ZA201800913B (en)	2022-07-27	Syk inhibitors
IL243578A0 (en)	2016-02-29	syk inhibitors
IL243577A0 (en)	2016-02-29	Formulation of syk inhibitors
GB201421334D0 (en)	2015-01-14	Synthesis of aeizeolite
EP2951178A4 (en)	2016-07-06	VMAT2 INHIBITORS OF BENZOQUINOLONE TYPE
GB201410735D0 (en)	2014-07-30	Method of inhibiting DYRK1B
IL240593A0 (en)	2015-09-24	Novel inhibitory compounds of type a10 phosphodiesterase
EP2994124A4 (en)	2017-01-18	INHIBITORS OF METALLO-ß-LACTAMASE-ENZYMES
IL240763A0 (en)	2015-10-29	The halopyrazoles as thrombin inhibitors
ZA201507100B (en)	2017-03-29	Synthesis of bace1 inhibitors
ZA201508010B (en)	2017-01-25	Inhibitors of metastasis
IL241475A0 (en)	2015-11-30	method for synthesis
EP2959896A4 (en)	2016-08-17	INHIBITOR OF PHOSPHORYLATION OF PROTEIN T
GB201320732D0 (en)	2014-01-08	Methods of chemical synthesis
SG10201701021XA (en)	2017-04-27	Method of synthesis